Finch Therapeutics Group, Inc. FNCHQ
10.35
0.00
0.00%
as of 24 Sep
- Market cap
- $1.6M
- P/E
- 0.0×
Follow FNCHQ
Growth Flags
show if company had growth for consecutive years
| Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/S ratio |
9.99 | 25.15 | 21.07 | 22.47 | 22.47 | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
P/Operating CF |
(1.65) | (1.52) | (28.32) | (16.87) | (16.87) | — |
P/B ratio |
0.27 | 0.23 | 1.93 | 0.00 | 0.00 | — |
Price to Tangible BV |
0.00 | 0.34 | 2.12 | 0.00 | 0.00 | — |
EV/Sales |
15.97 | (40.34) | 14.13 | 9.79 | 9.79 | — |
EV/EBITDA |
0.00 | 0.32 | 0.00 | 0.00 | 0.00 | — |
EV/Operating CF |
(0.31) | 0.46 | (3.90) | (2.41) | (2.41) | — |
EV/FCF |
(0.32) | 0.45 | (3.15) | (2.22) | (2.22) | — |
Quick Ratio |
6.15 | 4.85 | 9.06 | 8.78 | 6.41 | — |
Current Ratio |
6.33 | 5.08 | 9.64 | 9.24 | 6.64 | — |
Net Debt/EBITDA |
0.31 | 0.51 | 2.23 | 2.53 | (4.89) | — |
Debt/Assets |
0.00% | 8.99% | 2.17% | 1.09% | 132.23% | 0.00% |
Debt/Equity |
0.00 | 0.15 | 0.02 | 0.01 | (2.40) | — |
Asset Turnover |
0.00 | 0.00 | 0.09 | 0.06 | 0.19 | — |
Operating CF/Net income |
0.42 | 0.65 | 1.15 | 0.80 | 0.83 | — |
Capex/Depreciation |
0.87 | (0.40) | (6.92) | (3.33) | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (126.06%) | (76.96%) | (109.21%) | 50.68% | 26.74% | — | |
| (68.48%) | (59.05%) | (29.77%) | (28.76%) | (38.34%) | — | |
ROIC |
0.00% | (183.71%) | (50.92%) | (62.50%) | 0.00% | — |
Return on Tangible Assets |
(334.37%) | (151.25%) | (39.46%) | (38.69%) | (46.04%) | — |
Average Days of Receivables |
0.00 | 61.05 | 9.73 | 51.78 | 170.60 | — |
Research and Development Expense of Revenue |
6,728.04% | 6,139.72% | 309.08% | 429.38% | 227.11% | — |
Selling, General and Administrative Expense of Revenue |
25,149.53% | 4,203.48% | 114.60% | 181.51% | 73.26% | — |
Intangible Assets out of Total Assets |
0.00 | 0.20 | 0.08 | 0.11 | 0.47 | 0.00 |
Share Based Compensation of Revenue |
1,802.80% | 911.03% | 22.45% | 40.15% | 0.00% | — |
Graham Net Nets |
(1.08) | 0.34 | 0.31 | 0.45 | 0.45 | — |
Graham Number |
0.00 | 0.00 | 0.00 | 1,073.24 | 0.00 | — |
Earnings Yield |
(1,247.91%) | (531.37%) | (19.38%) | (22.68%) | (22.68%) | — |
Free Cash Flow Yield |
(492.21%) | (355.72%) | (21.27%) | (19.58%) | (19.58%) | — |
Revenue per Share |
0.07 | 0.54 | 14.20 | 28.46 | 6.31 | — |
Operating CF per Share |
(19.63) | (47.08) | (51.43) | (115.52) | (10.76) | — |
Capex per Share |
0.83 | (1.37) | (12.20) | (9.71) | 0.00 | — |
Free Cash Flow per Share |
(18.80) | (48.45) | (63.62) | (125.23) | (10.76) | — |
Cash per Share |
15.65 | 44.68 | 102.25 | 367.66 | 26.22 | — |
Shareholders Equity per Share |
14.26 | 60.20 | 154.91 | 506.40 | (37.00) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
14.26 | 60.20 | 154.91 | 506.40 | (37.00) | — |
Free Cash Flow |
(30.18) | (77.03) | (83.05) | (33.96) | (17.32) | — |
Working Capital |
21.76 | 59.86 | 127.76 | 94.68 | 41.30 | — |
Capital Expenditures |
1.33 | (2.18) | (15.92) | (2.63) | (1.00) | — |
Net Current Asset Value |
(6.64) | 7.32 | 119.41 | 78.16 | (119.17) | — |
EV/EBIT |
0.00 | 0.30 | 0.00 | 0.00 | 0.00 | — |
Capex to Sales |
(12.40) | 2.53 | 0.86 | 0.34 | 0.00 | — |
Net Profit Margin |
(69,863.55%) | (13,315.45%) | (313.84%) | (509.66%) | (204.39%) | — |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other line items | ||||||
Depreciation/Fixed assets |
2.56 | 0.35 | 0.12 | 0.11 | 0.13 | — |
Cash ROIC |
(66.86%) | (50.05%) | (25.48%) | (16.05%) | (16.77%) | — |
Accounts Receivable Turnover |
0.00 | 2.70 | 23.33 | 2.64 | 3.48 | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.49 | — |
Inventory Turnover |
— | 0.00 | — | — | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 300.35 | — |
Days of Inventory on Hand |
— | 0.00 | — | — | 19.72 | — |
Average Receivables |
— | 0.32 | 0.79 | 2.92 | 2.92 | — |
Average Payables |
0.62 | 2.42 | 3.18 | 1.64 | 1.64 | — |
Average Assets |
109.16 | 194.15 | 195.35 | 136.80 | 54.13 | — |
Average Common Equity |
59.30 | 148.97 | 53.25 | (77.63) | (77.63) | — |
Columns are period end dates